New ANDA Cases

Summer 2017

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Altaire Pharms., Inc. v. Paragon Bioteck, Inc., 17-1837 (E.D.N.Y.) Mar. 31, 2017 Hon. William F. Kuntz, II phenylephrine HCl ophthalmic solution 8,859,623
Mallinckrodt IP v. B. Braun Medical Inc., 17-0365 (D. Del.) Apr. 3, 2017 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012 6,992,218
Mallinckrodt IP v. B. Braun Medical Inc., 17-1521 (E.D. Pa.) Apr. 4, 2017 Hon. Jeffrey L. Schmehl Ofirmev® (acetaminophen for injection) 9,399,012 6,992,218
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01100 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 8,853,260
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01101 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01103 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01104 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
Bristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc., 17-0374 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Breckenridge Pharm., Inc., 17-0375 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Hetero USA Inc., 17-0376 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Invagen Pharms., Inc., 17-0377 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Lupin Ltd., 17-0378 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Mylan Pharms. Inc., 17-0379 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sunshine Lake Pharma Co., Ltd., 17-0380 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Torrent Pharms. Ltd., 17-0381 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Unichem Labs., Ltd., 17-0382 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Gilead Sciences, Inc. v. Amneal Pharms., LLC, 17-2335 (D.N.J.) Apr. 6, 2017 Hon. Michael A. Shipp Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) 6,642,245 6,703,396 8,716,264
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 17-0389 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews Afinitor Disperz® (everolimus tablets) 5,665,772 8,778,962 8,617,598
Purdue Pharma L.P. v. Intellipharmaceutics Int’l Inc., 17-0392 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976 9,073,933 9,522,919 9,492,389 9,492,391 8,309,060
Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 17-0393 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 9,006,224 8,410,131 8,778,962 8,436,010
Dexcel Pharma Technologies Ltd. v. Apotex Corp., 17-2423 (D.N.J.) Apr. 7, 2017 Hon. Susan D. Wigenton omeprazole delayed-release tablets 9,023,391 7,255,878
Shire-NPS Pharms., Inc. v. Ambio, Inc., 17-0397 (D. Del.) Apr. 10, 2017 Hon. Gregory M. Sleet Gattex® (teduglutide for Injection) 7,056,886 7,847,061 9,060,992
Bristol-Myers Squibb Co. v. Accord Healthcare Inc., 17-0398 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Apotex, Inc., 17-0399 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945 6,413,980
Bristol-Myers Squibb Co. v. Bionpharma Inc., 17-0400 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Dr. Reddy’s Labs., Ltd., 17-0401 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Emcure Pharms. Ltd., 17-0402 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Impax Labs., Inc., 17-0403 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Indoco Remedies Ltd., 17-0404 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Macleods Pharms. Ltd., 17-0405 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Micro Labs USA Inc., 17-0406 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sandoz Inc., 17-0407 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sigmapharm Labs., LLC, 17-0408 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sun Pharm. Indus. Inc., 17-0409 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc., 17-0410 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Wockhardt Bio AG, 17-0411 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Zydus Pharms. (USA) Inc., 17-0412 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 17-2448 (D.N.J.) Apr. 10, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122 7,456,160 8,329,680 8,466,139
Jazz Pharms., Inc. v. Amneal Pharms. LLC, 17-2452 (D.N.J.) Apr. 10, 2017 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,539,330
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 17-0054 (N.D.W.V.) Apr. 10, 2017 Hon. Irene M. Keeley Afinitor Disperz® (everolimus tablets) 5,665,772 8,778,962 8,617,598
Celgene Corp. v. Zydus Pharms. (USA) Inc., 17-2528 (D.N.J.) Apr. 12, 2017 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800 7,855,217 7,968,569 8,530,498 8,648,095 9,101,621 9,101,622
Bristol-Myers Squibb Co. v. Mylan Pharms. Inc., 17-0055 (N.D.W.V.) Apr. 12, 2017 Hon. Irene M. Keeley Eliquis® (apixaban tablets) 6,967,208 9,326,945
Novartis Pharms. Corp. v. Breckenridge Pharm., Inc., 17-0420 (D. Del.) Apr. 13, 2017 Hon. Richard G. Andrews Affinitor® (everolimus tablets) 5,665,772 8,410,131 8,778,962
Millennium Pharms., Inc. v. Amneal Pharms. LLC, 17-0422 (D. Del.) Apr. 13, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446 6,958,319
Millennium Pharms., Inc. v. Zydus Pharms. (USA) Inc., 17-0423 (D. Del.) Apr. 13, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446 6,958,319
Bristol-Myers Squibb Co. v. Prinston Pharm. Inc., 17-0426 (D. Del.) Apr. 13, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Eli Lilly and Co. v. Dr. Reddy’s Labs., Inc., 17-2541 (D.N.J.) Apr. 13, 2017 Hon. Kevin McNulty Cialis® (tadalafil tablets) 6,943,166
Sucampo AG v. Amneal Pharms. LLC, 17-2577 (D.N.J.) Apr. 13, 2017 Hon. Peter G. Sheridan Amitiza® (lubiprostone capsules) 6,982,283 8,097,653 8,389,542 8,026,393 8,338,639
Eli Lilly and Co. v. Par Pharm., Inc., 17-1219 (S.D. Ind.) Apr. 18, 2017 Hon. William T. Lawrence Axiron® (testosterone metered transdermal solution) 8,435,944 8,993,520 9,180,194 8,419,307 8,177,449 8,807,861 9,289,586
AstraZeneca Pharms. LP v. HBT Labs., Inc., 17-2652 (D.N.J.) Apr. 18, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122 7,456,160 8,329,680 8,466,139
Par Pharm., Inc. v. Sumitomo Dainippon Pharma Co., Ltd., IPR2017-01292 (PTAB) Apr. 18, 2017 N/A Latuda® (lurasidone hydrochloride tablets) 9,555,027
Ferring Pharms. Inc. v. Teva Pharms. USA, Inc., 17-0435 (D. Del.) Apr. 19, 2017 Hon. Richard G. Andrews Prepopik® (sodium picosulfate / magnesium oxide / citric acid oral solution) 8,450,338 8,481,083
Meda Pharms. Inc. v. Akorn, Inc., 17-0439 (D. Del.) Apr. 19, 2017 Hon. Gregory M. Sleet Astepro® (azelastine HCl nasal spray) 8,071,073 8,518,919
Onyx Therapeutics, Inc. v. Teva Pharms. USA, Inc., 17-0449 (D. Del.) Apr. 20, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042 7,232,818 7,491,704 7,737,112 8,129,346 8,207,125 8,207,126 8,207,127 8,207,297
Purdue Pharma L.P. v. Abhai, LLC, 17-0450 (D. Del.) Apr. 20, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,492,389 9,492,391 9,492,392 9,492,393 9,522,919
Amneal Pharms. LLC v. Pfizer Inc., 17-0454 (D. Del.) Apr. 20, 2017 Vacant Judgeship (2017) Zithromax® (azithromycin oral suspension) 6,268,489
Eli Lilly and Co. v. Par Pharm., Inc., 17-0456 (D. Del.) Apr. 21, 2017 Hon. Leonard P. Stark Axiron® (testosterone metered transdermal solution) 8,435,944 8,993,520 9,180,194 8,419,307 8,177,449 8,807,861 9,289,586
Bayer Intellectual Property GMBH v. Taro Pharm. Indus. Ltd., 17-0462 (D. Del.) Apr. 21, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Purdue Pharms. LP v. Collegium Pharm., Inc., 17-10690 (D. Mass.) Apr. 21, 2017 Hon. F. Dennis Saylor, IV OxyContin® (oxycodone HCl extended-release tablets) 9,522,919
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 17-2754 (D.N.J.) Apr. 21, 2017 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Allergan Sales, LLC v. Teva Pharms. USA, Inc., 17-0343 (E.D. Tex.) Apr. 21, 2017 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Galderma Labs., L.P. v. Actavis Labs UT, Inc., 17-1076 (N.D. Tex.) Apr. 21, 2017 Hon. Barbara M.G. Lynn Soolantra® (ivermectin cream) 8,362,069 8,815,816 9,089,587 9,233,117 9,233,118
Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., 17-2877 (D.N.J.) Apr. 26, 2017 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 9,561,177
Ferring Pharms. Inc. v. Serenity Pharms., LLC, 17-0479 (D. Del.) Apr. 28, 2017 Hon. Gregory M. Sleet Noctiva® (desmopressin acetate nasal spray) 7,405,203 7,579,321 7,799,761
Bayer Intellectual Property GMBH v. Aurobindo Pharma Ltd., 17-0483 (D. Del.) Apr. 28, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Celgene Corp. v. Par Pharm., Inc., 17-3159 (D.N.J.) 4-May-17 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 8,198,262 8,673,939 8,735,428 8,828,427
Helsinn Healthcare S.A. v. Virtus Pharms., LLC, 17-3216 (D.N.J.) 4-May-17 Hon. Mary L. Cooper Aloxi® (palonosetron HCl for injection) 7,947,724 7,947,725 7,960,424 8,598,219 8,729,094
Depomed, Inc. v. Strides Pharma, Inc., 17-3180 (D.N.J.) 5-May-17 Hon. Jose L. Linares Zipsor® (diclofenac potassium capsules) 7,662,858 7,884,095 7,939,518 8,110,606 8,623,920 9,561,200
Takeda Pharm. Co. Ltd. v. Torrent Pharms. Ltd., 17-3186 (D.N.J.) 5-May-17 Hon. Stanley R. Chesler Nesina® (alogliptin benzoate tablets) Oseni® (alogliptin benzoate / pioglitazone HCl tablets) Kazano® (alogliptin benzoate / metformin HCl tablets) 7,807,689 8,173,663 8,288,539 8,900,638
Rhodes Pharms. L.P. v. Ascent Pharms. Inc., 17-2755 (E.D.N.Y.) 5-May-17 Hon. Pamela K. Chen Dilaudid® (hydromorphone HCl oral solution) 6,589,960
Astellas Pharma Inc. v. Roxane Labs., Inc., 17-0542 (D. Del.) 9-May-17 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517 8,183,274 9,126,941
Impax Labs., Inc. v. Actavis Labs. FL, Inc., 17-3295 (D.N.J.) 9-May-17 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa capsules) 9,533,046
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 17-3342 (D.N.J.) 11-May-17 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,539,335
Celgene Corp. v. Hetero Labs Ltd., 17-3387 (D.N.J.) 11-May-17 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 8,198,262 8,673,939 8,735,428 8,828,427
Novo Nordisk Inc. v. Glenmark Pharms. Ltd., 17-3462 (D.N.J.) 11-May-17 Hon. Michael A. Shipp Vagifem® (estradiol vaginal tablets) 7,018,992
Bayer Intellectual Property GMBH v. Micro Labs Ltd., 17-0560 (D. Del.) 12-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Argentum Pharms. LLC v. Kaken Pharm. Co., Ltd., IPR2017-01429 (PTAB) 12-May-17 N/A Jublia® (efinaconazole topical solution) 7,214,506
Micro Labs Ltd. v. Santen Pharm. Co., Ltd., IPR2017-01434 (PTAB) 12-May-17 N/A Zioptan® (tafluprost ophthalmic solution) 5,886,035
Taro Pharms. U.S.A., Inc. v. Apotex Technologies, Inc., IPR2017-01446 (PTAB) 17-May-17 N/A Ferriprox® (deferiprone oral solution/tablets) 7,049,328
Bayer Intellectual Property GMBH v. Mylan Pharms. Inc., 17-0584 (D. Del.) 19-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Genzyme Corp. v. Ingenus Pharms. LLC, 17-0602 (D. Del.) 24-May-17 Hon. Leonard P. Stark Clolar® (clofarabine for injection) 5,661,136
Acorda Therapeutics, Inc. v. Micro Labs Ltd., 17-3724 (D.N.J.) 24-May-17 Hon. Brian R. Martinotti Ampyra® (dalfampridine extended-release tablets) 8,007,826 8,354,437 8,440,703 8,663,685
Bayer Intellectual Property GMBH v. Sigmapharm Labs., LLC, 17-0648 (D. Del.) 26-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Upsher-Smith Labs., Inc. v. Glenmark Pharms. Ltd., 17-0649 (D. Del.) 26-May-17 Vacant Judgeship (2017) Qudexy® XR (topiramate extended-release capsules) 8,652,527 8,889,190 9,101,545 9,555,005
Mallinckrodt IP v. B. Braun Medical Inc., 17-0660 (D. Del.) 31-May-17 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012 9,610,265
Allergan Inc. v. Taro Pharm. Industries Ltd., 17-0663 (D. Del.) 1-Jun-17 Vacant Judgeship (2017) Aczone® (dapsone gel) 9,517,219
Osi Pharms., LLC v. Hetero USA Inc., 17-0665 (D. Del.) 1-Jun-17 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Osi Pharms., LLC v. Sun Pharms. Industries Inc., 17-0666 (D. Del.) 1-Jun-17 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Forest Labs., LLC v. Macleods Pharms., Ltd., 17-0672 (D. Del.) 2-Jun-17 Hon. Leonard P. Stark Namenda XR® (memantine HCl extended-release capsules) 8,039,009 8,168,209 8,173,708 8,283,379
Forest Labs., LLC v. Macleods Pharms., Ltd., 17-0673 (D. Del.) 2-Jun-17 Hon. Leonard P. Stark Namzaric® (memantine HCl / donepezil HCl extended-release capsules) 8,039,009 8,058,291 8,338,485 8,338,486 8,580,858
Mallinckrodt IP v. B. Braun Medical Inc., 17-2474 (E.D. Pa.) 2-Jun-17 Hon. Jeffrey L. Schmehl Ofirmev® (acetaminophen for injection) 9,399,012 9,610,265
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 17-0677 (D. Del.) 5-Jun-17 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets) 9,486,412 9,486,413 9,492,389 9,492,390 9,492,391 9,545,380 9,517,236 9,572,779 9,572,804
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland GMBH, IPR2017-01526 (PTAB) 5-Jun-17 N/A Lantus® (insulin glargine recombinant for injection) 7,476,652
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland GMBH, IPR2017-01528 (PTAB) 5-Jun-17 N/A Lantus® (insulin glargine recombinant for injection) 7,713,930
Pfizer Inc. v. Macleods Pharms., Ltd., 17-0683 (D. Del.) 6-Jun-17 Hon. Richard G. Andrews Viagra® (sildenafil citrate tablets) 6,469,012
Amgen Inc. v. Piramal Healthcare UK Ltd., 17-0713 (D. Del.) 9-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
AstraZeneca LP v. Apotex Inc., 17-0714 (D. Del.) 9-Jun-17 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) RE46,276 7,250,419 7,265,124
Argentum Pharms. LLC v. Novartis A.G., IPR2017-01550 (PTAB) 9-Jun-17 N/A Gilenya® (fingolimod capsules) 9,187,405
Par Pharm., Inc. v. MonoSol Rx, LLC, IPR2017-01557 (PTAB) 9-Jun-17 N/A Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 8,603,514
Noden Pharma DAC v. Anchen Pharms., Inc., 17-0728 (D. Del.) 12-Jun-17 Vacant Judgeship (2017) Tekturna® (aliskiren hemifumarate tablets) 8,617,595
Kowa Co., Ltd. v. Hetero Drugs Ltd., 17-4421 (S.D.N.Y.) 12-Jun-17 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 8,557,993
Dr. Reddy’s Labs. S.A. v. MonoSol Rx, LLC, IPR2017-01582 (PTAB) 12-Jun-17 N/A Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 8,603,514
Breckenridge Pharm., Inc. v. Novartis Pharms. Corp., IPR2017-01592 (PTAB) 12-Jun-17 N/A Afinitor® (everolimus tablets) 8,410,131
Orexo AB v. Actavis Elizabeth LLC, 17-0758 (D. Del.) 14-Jun-17 Hon. Gregory M. Sleet Zubsolv® (buprenorphine HCl / naloxone HCl dehydrate sublingual tablets) 9,259,421 8,940,330
Kowa Co., Ltd. v. Hetero Drugs Ltd., 17-0762 (D. Del.) 14-Jun-17 Hon. Gregory M. Sleet Livalo® (pitavastatin calcium tablets) 8,557,993
Cosmo Technologies Ltd. v. Sun Pharm. Industries, Ltd., 17-4393 (D.N.J.) 15-Jun-17 Hon. Peter G. Sheridan Uceris® (budesonide extended-release tablets) 9,320,716
Belcher Pharms., LLC v. Hospira, Inc., 17-0775 (D. Del.) 19-Jun-17 Hon. Leonard P. Stark Abboject® (epinephrine for injection) 9,283,197
Omeros Corp. v. Sandoz Inc., 17-0799 (D. Del.) 21-Jun-17 Hon. Richard G. Andrews Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Omeros Corp. v. Sandoz Inc., 17-4564 (D.N.J.) 21-Jun-17 Hon. Brian R. Martinotti Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Watson Labs., Inc. v. United Therapeutics, Inc., IPR2017-01621 (PTAB) 21-Jun-17 N/A Tyvaso® (treprostinil solution for inhalation) 9,358,240
Watson Labs., Inc. v. United Therapeutics, Inc., IPR2017-01622 (PTAB) 21-Jun-17 N/A Tyvaso® (treprostinil solution for inhalation) 9,339,507
Omeros Corp. v. Lupin Ltd., 17-0803 (D. Del.) 22-Jun-17 Hon. Richard G. Andrews Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Omeros Corp. v. Lupin Ltd., 17-4595 (D.N.J.) 22-Jun-17 Hon. Brian R. Martinotti Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Aurobindo Pharma USA Inc. v. Andrx Corp., IPR2017-01648 (PTAB) 22-Jun-17 N/A Fortamet® (metformin HCl extended-release tablets) Actoplus® Met XR (metformin HCl / pioglitazone HCl extended-release tablets) 6,866,866
Teijin Ltd. v. Indoco Remedies Ltd., 17-0809 (D. Del.) 23-Jun-17 Vacant Judgeship (2017) Uloric® (febuxostat tablets) 7,361,676 8,372,872 9,107,912
Bayer Intellectual Property GMBH v. Invagen Pharms., Inc., 17-0812 (D. Del.) 23-Jun-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Amgen Inc. v. Alkem Labs. Ltd., 17-0815 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Lupin Ltd., 17-0816 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Macleods Pharms., Ltd., 17-0817 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Aurobindo Pharma USA Inc. v. Andrx Corp., IPR2017-01673 (PTAB) 23-Jun-17 N/A Fortamet® (metformin HCl extended-release tablets) Actoplus® Met XR (metformin HCl / pioglitazone HCl extended-release tablets) 6,790,459
Biogen Int’l GMBH v. Amneal Pharms. LLC, 17-0823 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,399,514
Biogen Int’l GMBH v. Aurobindo Pharma U.S.A., Inc., 17-0824 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Hetero USA Inc., 17-0825 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen MA Inc. v. Impax Labs., Inc., 17-0826 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Prinston Pharm. Inc., 17-0827 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Slayback Pharma LLC, 17-0828 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen Int’l GMBH v. Teva Pharms. USA, Inc., 17-0829 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Concert Pharms., Inc. v. Incyte Corp., PGR2017-00034 (PTAB) 27-Jun-17 N/A Jakafi® (ruxolitinib phosphate tablets) 9,662,335
Biogen MA Inc. v. MSN Labs. Private Ltd, 17-0845 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Graviti Pharms Pvt. Ltd, 17-0846 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Shilpa Medicare Ltd., 17-0847 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Sun Pharma Global FZE, 17-0848 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Windlas Healthcare, Pvt. Ltd., 17-0849 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen Int’l GMBH v. Alkem Labs. Ltd., 17-0850 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Cipla Ltd., 17-0851 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Glenmark Pharms. Ltd., 17-0852 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Lupin Atlantis Holdings SA, 17-0853 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Torrent Pharms. Ltd., 17-0854 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Pharmathen S.A., 17-0855 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. TWi Pharms., Inc., 17-0856 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Macleods Pharms., Ltd., 17-0857 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Sebela Int’l Ltd. v. Actavis Labs. FL, Inc., 17-4789 (D.N.J.) 28-Jun-17 Hon. Claire C. Cecchi Brisdelle® (paroxetine capsules) 9,393,237
Biogen Int’l GMBH v. Stason Pharms., Inc., 17-1133 (C.D. Cal.) 30-Jun-17 Hon. Douglas F. McCormick Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. Sandoz Inc., 17-1606 (D. Col.) 30-Jun-17 Hon. Michael E. Hegarty Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Forest Labs., LLC v. Sun Pharma Global FZE, 17-0865 (D. Del.) 30-Jun-17 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 8,933,030
Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 17-0867 (D. Del.) 30-Jun-17 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
Biogen Int’l GMBH v. Accord Healthcare Inc., 17-0872 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Par Pharm., Inc., 17-0873 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Sandoz Inc., 17-0874 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Sawai USA, Inc., 17-0875 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. Accord Healthcare Inc., 17-0612 (M.D.N.C.) 30-Jun-17 Hon. William L. Osteen, Jr. Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Zydus Pharms. (USA) Inc., 17-4857 (D.N.J.) 30-Jun-17 Hon. Brian R. Martinotti Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Par Pharm., Inc., 17-4984 (S.D.N.Y.) 30-Jun-17 Hon. Jesse M. Furman Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Mylan Pharms. Inc., 17-0116 (N.D.W.V.) 30-Jun-17 Hon. Irene M. Keeley Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Back to Top